Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q4 EPS of ($0.47), $0.03 worse than the analyst estimate of ($0.44).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.